-
Syros Announces Board of Directors Appointment
americanpharmaceuticalreview
December 24, 2019
Syros Pharmaceuticals announced the appointment of Mark Alles to the Company’s Board of Directors.
-
Progenity Announces Expansion of Board of Directors
firstwordpharma
February 24, 2019
Progenity's pipeline of precision medicine solutions under development includes novel products for noninvasive prenatal screening for monogenic diseases, and assays related to preeclampsia, preterm birth, oncology, and others. Progenity also aims to trans
-
Insmed appoints Leo Lee to its Board of Directors
biospectrumasia
May 21, 2018
Lee has more than 21 years of experience in the pharmaceutical industry in Japan.
-
BeiGene appoints J. Samuel Su to its Board of Directors
biospectrumasia
April 10, 2018
BeiGene is advancing a pipeline consisting of novel oral small molecules and monoclonal antibodies for cancer
-
Colleen Goggins Joins QuintilesIMS Board of Directors
quintilesims
August 01, 2017
QuintilesIMS (NYSE:Q), a leading provider of information, technology solutions and contract research services to the life sciences industry, announced the appointment of Colleen Goggins to its board of directors.
-
ARMO BioSciences Appoints Naiyer A. Rizvi, M.D. to Board of Directors
americanpharmaceuticalreview
June 29, 2017
ARMO BioSciences announced the appointment of Naiyer A. Rizvi, M.D. to its Board of Directors. Dr. Rizvi is the Director of Thoracic Oncology and Co-Director of Cancer Immunotherapy in the Division of Hematology and Oncology at Columbia University Medical
-
California Life Sciences Association Adds to Board of Directors
americanpharmaceuticalreview
May 09, 2017
California Life Sciences Association (CLSA) announced an expansion of its board of directors by adding Wade Ackerman, Partner at Covington & Burling LLP and Richard Ascroft, Vice President, Managed Market and Government Affairs at Takeda Pharmaceuticals.
-
Ronald E. Blaylock elected to Pfizer's Board of Directors
worldpharmanews
February 27, 2017
Pfizer Inc. has announced the election of Ronald E. Blaylock to its Board of Directors, effective immediately. Mr. Blaylock was also appointed to the Corporate Governance and Science and Technology Committees of Pfizer's Board.
-
Oxford BioTherapeutics Strengthens Board of Directors with Appointment of Two Biotech Veterans
firstwordpharma
February 10, 2017
Oxford BioTherapeutics ("OBT") announced a significant strengthening of its oncology focused Board of Directors with the appointment of Bernd Seizinger M.D., Ph.D. as Chairman and Jean-Pierre Bizzari, M.D. as a non-executive director.
-
Carolyn R. Bertozzi, Ph.D., Elected to Lilly Board of Directors
lilly
February 10, 2017
The board of directors of Eli Lilly and Company (NYSE: LLY) has elected Carolyn R. Bertozzi, Ph.D., as a new member, effective Feb. 10, 2017. As a member of Lilly's board, she will serve on the Science and Technology and Public Policy and Compliance Commi